3,532
Views
9
CrossRef citations to date
0
Altmetric
Editorials

Rare diseases and orphan drugs in Japan: developing multiple strategies of regulation and research

, &
Pages 681-683 | Published online: 26 Aug 2013

Bibliography

  • Japan Intractable Diseases Information Center. What is an intractable disease? Available from: http://www.nanbyou.or.jp [Last accessed 16 June 2013]
  • Song PP, Kokudo N. Revision of measures to combat intractable diseases in Japan: three pillars will play an even greater role in the future. Intractable Rare Dis Res 2013;2:33-4
  • Song PP, Gao JJ, Inagaki Y, et al. Rare diseases, orphan drugs, and their regulation in Asia: current status and future perspectives. Intractable Rare Dis Res 2012;1:3-9
  • Makoto S, Kiyohito N. Development of orphan drugs in Japan: effects of a support system for development of orphan drugs in Japan. Drug Inf J 2000;34:829-37
  • Makoto S, Kiyohito N. Development of orphan drugs in Japan: characteristics of orphan drugs developed in Japan. Drug Inf J 2000;34:839-46
  • Franco P. Orphan drugs: the regulatory environment. Drug Discov Today 2013;18:163-72
  • Lexchin J. Do manufacturers of brand-name drugs engage in price competition? An analysis of introductory prices. CMAJ 2006;174:1120-1
  • Denis A, Mergaert L, Fostier C, et al. A comparative study of European rare disease and orphan drug markets. Health Policy 2010;97:173-9
  • Song P, Gao J, Inagaki Y, et al. Intractable and rare diseases research in Asia. Biosci Trends 2012;6(2):48-51
  • The Japanese Ministry of Health, Labour, and Welfare. Reform of measures to combat intractable diseases. Available from: http://www.mhlw.go.jp/stf/shingi/2r9852000002n6ro-att/2r9852000002n6uj.pdf [Last accessed 25 June 2013]; in Japanese
  • Song PP, Gao JJ, Kokudo N, Tang W. New opportunity for orphan drug development in Japan: early exploratory clinical trial bases promote drug translation from basic studies to clinical application. Intractable Rare Dis Res 2012;1:95-7
  • Inagaki Y, Song PP. Necessity of cooperation with government on publication of scientific research results for intractable diseases. Intractable Rare Dis Res 2013;2:69-71
  • EURORDIS. Survey of the delay in diagnosis for 8 rare diseases in Europe (Eurordiscare 2). Available from: http://archive eurordis.org/article.php3?id_article=454 [Last accessed 1 July 2013]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.